Form 4 for AVTR Avantor, Inc.
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-20 · accession 0001722482-25-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-24 | 2025-02-20 | AVTR | Gourdier Benoit | EVP, Bioscience Production | A - Grant | $0.00 | +35.7K | 76.9K | +87% | $0 |
| D | 2025-02-24 | 2025-02-23 | AVTR | Gourdier Benoit | EVP, Bioscience Production | F - Tax | $17.30 | -2,842 | 74.1K | -4% | -$49.2K |
| D | 2025-02-24 | 2025-02-20 | AVTR | Gourdier Benoit | EVP, Bioscience Production | A - Grant | $0.00 | +86.6K | 86.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | A | A | 35,734 | $0.00 | 76,924 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-23 | F | D | 2,842 | $17.30 | 74,082 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2025-02-20 | A | A | 86,565 | $0.00 | 86,565 | D | $17.49 · — to 2035-02-20 | 86,565 Common Stock | (F3) Reflects a grant of stock options that vest in three equal annual installments beginning on February, 20, 2026. |